Home News Discover the latest breakthroughs, stories, and updates from Oncode Institute’s mission to outsmart cancer. Search Category Category Blog Post External Events Funding Research news Our Team press news New research puts the mode-of-action of T-cell immunotherapies in focus 26 Jul 2022 Looking towards the future, together 14 Jul 2022 Exciting research from the Kops and van Rheenen labs now published in Nature 13 Jul 2022 Oncode-PACT foundation officially established 12 Jul 2022 Oncode Investigators Marvin Tanenbaum and Michiel Vermeulen were honoured with the prestigious EMBO membership 6 Jul 2022 Vidi Grants awarded to Miao-Ping Chien, Rebekka Schneider, Tineke Lenstra and Monique Mulder 30 Jun 2022 Prostate cancer hijacks tumor cell biorhythm to evade hormone therapy 27 Jun 2022 Cell-free DNA biomarkers can help to identify treatment responders and non-responders of head and neck cancer patients 21 Jun 2022 2021: Running at Full Capacity 3 Jun 2022 Fully booked: Masterclass Nuclear organization in development and disease 30 May 2022 Cancer Research UK forms strategic alliance with Oncode Institute 10 May 2022 A new critical regulator of interferon signaling discovered 6 May 2022 Simmunext: where immunotherapy and chemistry meet 4 May 2022 In memoriam: Joop Kroes 3 May 2022 Missing enzyme identified: how MATCAP works and affects brain development 29 Apr 2022 Looking at science with new eyes 28 Apr 2022 Pagination Previous page ‹ … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Next page ›
Oncode Investigators Marvin Tanenbaum and Michiel Vermeulen were honoured with the prestigious EMBO membership 6 Jul 2022
Vidi Grants awarded to Miao-Ping Chien, Rebekka Schneider, Tineke Lenstra and Monique Mulder 30 Jun 2022
Cell-free DNA biomarkers can help to identify treatment responders and non-responders of head and neck cancer patients 21 Jun 2022
